" "
Keywords..

  • 6.3 Million patient years

    Creon® offers 6.3 million patient years' experience in managing PEI and a solid foundation of successful clinical trials providing a wealth of data.5

    See Creon®'s efficacy & tolerability for yourself

  • Creon®’s Unique Mode of Action

    Creon®’s optimally sized minimicrospheres and unique enteric coating ensure your PEI patients get the right dose.

    Find out how

  • What Does Untreated PEI Mean for Your Patients?

    • Reduced quality of life1
    • Higher risk of cardiovascular events2,3
    • Increased morbidity and mortality1
    Discover Creon®: The world's #1 prescribed PERT4

  • Creon® Dosing for Effective PEI Treatment

    With a wide range of strengths – from Creon® Micro (5,000) to Creon® 25,000 –  Creon® enables effective dosing to meet all your patients’ needs.

    Titrate to effective dosing

Pert treatment goals

Follow the Link  Refresh your knowledge

Effective Creon® Dosing

Follow the Link  Get up to date

Resources for practice & patient

Follow the Link  Find support

References

  1. Ockenga J. HPB 2009; 11(3): 11-5.
  2. Domínguez-Muñoz JE et al. J Gastroenterol Hepatol. 2011; 26(Suppl2): 12-6.
  3. Toouli J et al. Med J Aust. 2010; 193(8): 461-7.
  4. Data on file, RM27550; October 2014.
  5. Data on file, RM27559; July 2015.

You will now leave the Creon patient website and go to the Creon Track site where you can join the Creon Track patient support programme

Would you like to proceed to the Creon Track registration website?

OK
NO

© 2016 Mylan. All rights reserved.

Adverse events should be reported. This includes any possible side effects not listed in the package leaflet. You can also report side effects directly via the Yellow Card Scheme at www.mhra.gov.uk/yellowcard . By reporting side effects you can help provide more information on the safety of this medicine. You should also inform the company who markets Creon in the UK directly via ukpharmacovigilance@mylan.com or +44 (0)800 121 8267.

This content is intended for UK healthcare professionals.

Registered Number: 09429449 England, Registered Office: Trident Place, Building 4, Mosquito Way, Hatfield, Hertfordshire, England, AL10 9UL. CRE-2017-0191 August 2017.

Creon.co.uk is now part of Mylan.

For more information visit Mylan.co.uk
©2016 Mylan N.V. All Rights Reserved.